Neuren Pharmaceuticals reported AUD17.01M in EBIT for its fiscal semester ending in December of 2025.





Ebit Change Date
Akebia Therapeutics USD -5.45M 9.4M Dec/2025
Alaunos Therapeutics USD -952K 60K Jun/2026
Avita Medical AUD -6.17M 4.22M Jun/2026
Clinuvel Pharmaceuticals AUD 13.51M 15.95M Dec/2025
Dianthus Therapeutics USD -61.48M 14.95M Jun/2026
Genetic Signatures AUD -6.34M 1.67M Dec/2025
Ionis Pharmaceuticals USD -102.29M 15.71M Jun/2026
Medical Developments International AUD -36K 12.96M Dec/2025
Neuren Pharmaceuticals AUD 17.01M 154.09M Dec/2025
Organon & Co USD 377M 86M Sep/2026
PYC Therapeutics AUD -22.59M 3.25M Dec/2025
Starpharma Holdings AUD -873K 161K Dec/2025
Tectonic Therapeutic USD -24.22M 3.08M Jun/2026
Telix Pharmaceuticals AUD 46.36M 38.32M Jun/2026
Viatris USD 255.5M 181.8M Sep/2026
Xeris Pharmaceuticals USD -24.15M 33.27M Jun/2026